IGF::OT::IGF Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies

Information

• Research Project
• 9616161

• ApplicationId

  9616161

• Core Project Number

• Full Project Number

  261201700020C-1-0-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  8/1/2017 - 6 years ago

• Project End Date

  7/31/2018 - 5 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2018

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• ALCHEM LABORATORIES CORPORATION

The Developmental Therapeutics Program (DTP) at the National Cancer Institute (NCI) supports the NCI's Experimental Therapeutics (NExT) program to facilitate the transition of novel drug discoveries into clinical trials of new cancer therapeutic agents. One of essential parts of the program involves the manufacture and supply of bulk chemicals/drugs that are prepared under the current Good Manufacturing Practice (c-GMP). The bulk drugs will be used to support pre-clinical studies and to prepare clinical products that are necessary to support human clinical trials under the NCI sponsorship or investigator initiated INDs.

IC Name

• Activity

  N02

• Administering IC

  CA

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  671205

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

• Ed Inst. Type

• Funding ICs

  NCI:671205\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  ALCHEM LABORATORIES CORPORATION

• Organization Department

• Organization DUNS

  012852344

• Organization City

  ALACHUA

• Organization State

  FL

• Organization Country

  UNITED STATES

• Organization Zip Code

  326156687

• Organization District

  UNITED STATES